Gapping down
In reaction to earnings/guidance:
- EZPW -1.4%
M&A news:
- CATM -1.2% (to be acquired for $35.00 per share by funds affiliated with Apollo Global Management (APO) and Hudson Executive Capital (halted))
Other news:
- MIRM -16.3% (prices 3.75 mln shares of common stock at $20.00 per share)
- MESO -5.3% (reported top-line results for Phase 3 trial of rexlemestrocel-L in advanced chronic heart failure)
- EAF -5.2% (upsizes offering by 1.5 mln shares and prices offering 8.5 mln shares of common stock; details undisclosed)
- OCUL -3% (announced $75.0 mln public offering of common stock)
- GLSI -2.8% (announces option agreement for pre-clinical coronavirus vaccine candid)
- ZIOP -1.3% (CFO announced intention to depart, effective December 31)
- MTN -1.1% (announced convertible notes offering)
Analyst comments:
- IIVI -3.2% (downgraded to Equal-Weight from Overweight at Morgan Stanley)
- IPHA -1.8% (downgraded to Mkt Perform from Outperform at SVB Leerink)
- URI -1.2% (downgraded to Underweight from Equal-Weight at Morgan Stanley)
- BVN -1.1% (downgraded to Neutral from Buy at Goldman)